The role of osteoprotegerin in breast and prostate cancer

Eitemau Tebyg

• Serum osteoprotegerin (OPG) levels and disease progression in prostate cancer patients
  gan: Eaton, C, et al.
  Cyhoeddwyd: (2004)
• Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.
  gan: Holen, I, et al.
  Cyhoeddwyd: (2002)
• Osteoprotegerin is an anti-apoptotic factor produced by prostate cancer cells that is potentially involved in tumour survival and progression.
  gan: Holen, I, et al.
  Cyhoeddwyd: (2002)
• Serum osteoprotegerin (OPG) levels are associated with disease progression and response to androgen ablation in patients with prostate cancer.
  gan: Eaton, C, et al.
  Cyhoeddwyd: (2004)
• OPG is a survival factor for breast- and prostate cancer cells in vitro
  gan: Holen, I, et al.
  Cyhoeddwyd: (2002)